Headquarters and industrial site
Route de Bordeaux
47700 Casteljaloux
France
Commercial office
18-22 rue Marius Aufan
92300 Levallois-Perret
France
Pharmacovigilance plays an essential role in monitoring healthcare products, including medicines, vaccines, and dietary supplements. It ensures not only the effectiveness of the products released on the market but also their safety for consumers.
Pharmacovigilance plays an essential role in monitoring healthcare products, including medicines, vaccines, and dietary supplements. It ensures not only the effectiveness of the products released on the market but also their safety for consumers.
In a context where pharmaceutical and nutraceutical regulations are becoming increasingly stringent, pharmacovigilance has become a necessity for pharmaceutical companies.
This article explores what pharmacovigilance is, the best practices in pharmacovigilance, the stakeholders involved, and its importance for the industry.
Pharmacovigilance involves the continuous monitoring of adverse effects associated with the use of medications.
Its purpose is to detect, evaluate, and prevent the risks of adverse and side effects of medications, ensuring the safety of users.
Pharmacovigilance has three main objectives:
These actions collectively aim to continuously improve health products while minimizing risks associated with their use.
Pharmacovigilance is a process that applies to various types of health products, including:
In addition to the risks of side effects, pharmacovigilance also focuses on monitoring:
According to pharmaceutical regulations, pharmacovigilance involves the responsibility of multiple stakeholders within the pharmaceutical industry:
To learn more about pharmaceutical drug manufacturing, check out our full article.
Every pharmaceutical and nutraceutical company must appoint a pharmacovigilance officer to ensure regulatory compliance and minimize risks associated with their products. This officer is responsible for adhering to good pharmacovigilance practices.
This pharmacovigilance officer is specifically responsible for:
In Europe, institutions such as the National Agency for the Safety of Medicines and Health Products (ANSM) in France or the European Medicines Agency (EMA) oversee pharmacovigilance.
These regulatory institutions impose:
Good Pharmacovigilance Practices (GVP) define the roles of the various stakeholders involved in the pharmacovigilance process, namely: healthcare professionals, regional pharmacovigilance centres, pharmaceutical companies, and patients exposed to medications.
Pharmacovigilance helps protect users by:
Pharmacovigilance also helps maintain and strengthen patient trust in healthcare products.
Pharmacovigilance is a key process when establishing a pharmaceutical company. To learn how to start a pharmaceutical business, check out our dedicated article.
Implementing effective and rigorous pharmacovigilance processes offers significant advantages:
With the rise in dietary supplement consumption, regulations are becoming increasingly stringent. In response to heightened safety surveillance for dietary supplements, pharmacovigilance not only ensures compliance with regulatory safety requirements but also enables better risk management for these products.
Considering the challenges associated with pharmacovigilance in the pharmaceutical industry, it becomes evident that pharmacovigilance is a key success factor for players in the nutraceutical market. It not only reassures consumers about the quality of dietary supplements but also enables businesses to adapt to an ever-evolving regulatory framework, thereby enhancing competitiveness in a demanding market.